ArticleImmunotherapy2025
Cost-utility analysis of blinatumomab in pediatric patients with acute lymphoblastic leukemia in Iran.
Golara Nikakhtar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it